NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

感染管理市場成長機會、成長預測 (2021-2028年):各產品&服務、終端用戶、地區

Infection Control Market by Product & Service and End User : Global Opportunity Analysis and Industry Forecast, 2021-2028

出版商 Allied Market Research 商品編碼 1017311
出版日期 內容資訊 英文 220 Pages
商品交期: 2-3個工作天內
價格
感染管理市場成長機會、成長預測 (2021-2028年):各產品&服務、終端用戶、地區 Infection Control Market by Product & Service and End User : Global Opportunity Analysis and Industry Forecast, 2021-2028
出版日期: 2021年05月31日內容資訊: 英文 220 Pages
簡介

全球感染管理的市場規模在預測期間內預計以3.0%的年複合成長率發展,從2020年的326億1375萬美元,成長到2028年386億1677萬美元的規模。

外科手術數增加,院內感染的發生率上升,老年人口增加,殺菌設備的技術進步,全球的慢性疾病的發生率上升等要素,促進該市場的成長。還有醫院和製藥、醫療設備製造商殺菌服務的外包增加,環氧乙烷滅菌的再引進,電子束殺菌的使用增加,由於新型冠狀病毒感染疾病 (COVID-19) 的衛生意識的高漲也成為市場成長的促進因素。

本報告提供全球感染管理的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,市場規模的變化、預測,產品&服務、終端用戶、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等彙整資訊。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義、範圍
  • 主要調查結果
  • 波特的五力分析
  • 主要企業的地位
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • COVID-19:影響分析

第4章 市場分析、預測:產品、各服務

  • 主要趨勢、成長要素、成長機會
  • 市場規模、預測:各地區
  • 市場分析:各國
  • 殺菌
    • 殺菌劑
    • 契約殺菌服務
    • 殺菌消耗品、配件
  • 清洗、消毒產品
    • 消毒劑
    • 消毒設備
    • 其他
  • 保護阻隔
    • 醫療用不織布
    • 手套
  • 內視鏡重新處理產品

第5章 市場分析、預測:各終端用戶

  • 醫院、診療所
  • 製藥、醫療設備企業
  • 其他
    • 市場規模、預測:各地區
    • 市場分析:各國

第6章 市場分析、預測:各地區、主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 南美、中東、非洲
    • 主要趨勢、成長要素、成長機會
    • 市場規模、預測:各國
    • 市場規模、預測:產品、各服務
    • 市場規模、預測:各終端用戶

第7章 企業簡介

  • M COMPANY
  • BELIMED AG.
  • ECOLAB INC.
  • FORTIVE CORPORATION(ADVANCED STERILIZATION PRODUCTS).
  • GENITGE AB.
  • MATACHANA GROUP.
  • MIELE GROUP.(STEELCO)
  • MMM GROUP
  • SOTERA HEALTH INC.
  • STERIS PLC(CANTEL MEDICAL CORPORATION).
目錄
Product Code: A07453

The global infection control market was valued at $32,613.75 million in 2020, and is projected to reach $38,616.77 million by 2028, registering a CAGR of 3.0% from 2021 to 2028.

Infectious diseases are caused by microorganisms such as viruses, bacteria, parasites, or fungi. Infection can be classified into various types, which include hospital acquired infections (HAIs), ear infections, eye infections, lung & respiratory infections, skin infections, common childhood infections, sexually transmitted infections, and stomach & intestinal infections. These infections can be controlled through a number of products such as sterilization, cleaning & disinfection products, protective barriers, and endoscope reprocessing products. Protective barrier products include surgical gowns, face masks, coveralls, and others.

The growth of the infection control market is driven by rise in number of surgical procedures, increase in incidence of hospital-acquired infections, surge in geriatric population, technological advancements in sterilization equipment, and rise in incidence of chronic diseases across the globe. In addition, rise in outsourcing of sterilization services among hospitals, and pharmaceutical & medical device companies further boosts the growth of the market. Moreover, re-introduction of ethylene oxide sterilization, increase in use of E-beam sterilization, surge in awareness of environmental & personal hygiene due to COVID-19 is another factor that fuels the growth of the market. However, adverse effects of chemical disinfectants and concerns regarding the safety of reprocessed instruments are expected to restrain the growth of the infection control market. Conversely, rise in adoption of single use medical nonwovens and devices is expected to offer lucrative opportunities during the forecast period.

The infection control market is segmented into product & service, end user, and region. On the basis of product & service, the market is categorized into sterilization, cleaning & disinfection products, protective barriers, and endoscope reprocessing products. By sterilization, the market is divided into sterilization product, contract sterilization services, and sterilization consumables & accessories. The sterilization product segment is further classified into heat sterilization equipment, low temperature sterilization equipment, radiation sterilization equipment, and other sterilization equipment. The contract sterilization services segment is further divided into ethylene oxide sterilization, e-beam sterilization, gamma sterilization, and others. The sterilization consumables & accessories segment is further classified into sterilization indicators and packaging accessories. By cleaning & disinfection products, the market is divided into disinfectants, disinfectors equipment, and others. The disinfectants segment is further divided into wipes, liquids, and sprays. By protective barriers, the market is categorized into medical nonwoven and gloves. The medical nonwoven segment is further divided into surgical gowns, face masks, coveralls, and others. By end user, the market is categorized into hospitals & clinics, pharmaceutical & medical device companies, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2020 to 2028, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
  • A comprehensive analysis of four regions is provided to determine the existing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Product & Service

  • Sterilization
  • Sterilization Product
  • Heat Sterilization Equipment
  • Low Temperature Sterilization Equipment
  • Radiation Sterilization Equipment
  • Other Sterilization Equipment
  • Contract Sterilization Services
  • Ethylene Oxide Sterilization
  • E-beam Sterilization
  • Gamma Sterilization
  • Others
  • Sterilization Consumables & Accessories
  • Sterilization Indicators
  • Packaging Accessories
  • Cleaning & Disinfection Products
  • Disinfectants
  • Wipes
  • Liquids
  • Sprays
  • Disinfectors Equipment
  • Others
  • Protective Barriers
  • Medical Nonwoven
  • Surgical Gowns
  • Face Masks
  • Coveralls
  • Others
  • Gloves
  • Endoscope Reprocessing Products

By End User

  • Hospitals & Clinics
  • Pharmaceutical & Medical Device Companies
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
  • LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • 3M Company
  • Belimed AG
  • Ecolab Inc
  • Fortive (Advanced Sterilization Products)
  • Getinge AB
  • Matachana Group
  • Miele Group (Steelco SpA)
  • MMM Group
  • Sotera Health Llc
  • Steris Plc (Cantel Medical Corporation)
  • LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
  • Danaher Corporation (Metrex Research Llc)
  • Reckitt Benckiser
  • Pal International

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key Benefits for Stakeholders
  • 1.3.Key market segments
    • 1.3.1.List of key players profiled in the report
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
    • 3.2.2.Top winning strategies
  • 3.3.Porter's five force analysis
  • 3.4.Top player positioning, 2020
  • 3.5.Market dynamics
    • 3.5.1.Drivers
      • 3.5.1.1.Rise in incidence of hospital-acquired infections (HAIs)
      • 3.5.1.2.Upsurge in likelihood of epidemic or pandemic outbreaks
      • 3.5.1.3.Increase in geriatric population and rise in incidence of chronic diseases
      • 3.5.1.4.Rise in use of E-beam sterilization
    • 3.5.2.Restraint
      • 3.5.2.1.Adverse effects of chemical disinfectants
    • 3.5.3.Opportunities
      • 3.5.3.1.Growth opportunities in emerging markets
    • 3.5.4.Impact analysis
  • 3.6.Covid-19 Impact analysis on infection control market

CHAPTER 4:INFECTION CONTROL MARKET, BY PRODUCT & SERVICE

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Sterilization
    • 4.2.1.Key market trends, growth factors, and opportunities
    • 4.2.2.Market size and forecast, by region
    • 4.2.3.Market analysis, by country
    • 4.2.4.Market size and forecast, by type
      • 4.2.4.1.Sterilization product
      • 4.2.4.1.1.Market size and forecast
      • 4.2.4.1.2.Market size and forecast, by type
      • 4.2.4.1.2.1.Heat sterilization equipment
      • 4.2.4.1.2.1.1.Market size and forecast
      • 4.2.4.1.2.2.Low temperature sterilization equipment
      • 4.2.4.1.2.2.1.Market size and forecast
      • 4.2.4.1.2.3.Radiation sterilization equipment
      • 4.2.4.1.2.3.1.Market size and forecast
      • 4.2.4.1.2.4.Other sterilization equipment
      • 4.2.4.1.2.4.1.Market size and forecast
      • 4.2.4.2.Contract sterilization services
      • 4.2.4.2.1.Market size and forecast
      • 4.2.4.2.2.Market size and forecast, by type
      • 4.2.4.2.2.1.Ethylene oxide sterilization
      • 4.2.4.2.2.1.1.Market size and forecast
      • 4.2.4.2.2.2.E-beam sterilization
      • 4.2.4.2.2.2.1.Market size and forecast
      • 4.2.4.2.2.3.Gamma sterilization
      • 4.2.4.2.2.3.1.Market size and forecast
      • 4.2.4.2.2.4.Others
      • 4.2.4.2.2.4.1.Market size and forecast
      • 4.2.4.3.Sterilization consumables and accessories
      • 4.2.4.3.1.Market size and forecast
      • 4.2.4.3.2.Market size and forecast, by type
      • 4.2.4.3.2.1.Sterilization indicators
      • 4.2.4.3.2.1.1.Market size and forecast
      • 4.2.4.3.2.2.Packaging accessories
      • 4.2.4.3.2.2.1.Market size and forecast
  • 4.3.Cleaning & Disinfection Products
    • 4.3.1.Key market trends, growth factors, and opportunities
    • 4.3.2.Market size and forecast, by region
    • 4.3.3.Market analysis, by country
    • 4.3.4.Market size and forecast, by type
      • 4.3.4.1.Disinfectants
      • 4.3.4.1.1.Market size and forecast
      • 4.3.4.1.2.Market size and forecast, by type
      • 4.3.4.1.2.1.Wipes
      • 4.3.4.1.2.1.1.Market size and forecast
      • 4.3.4.1.2.2.Liquids
      • 4.3.4.1.2.2.1.Market size and forecast
      • 4.3.4.1.2.3.Sprays
      • 4.3.4.1.2.3.1.Market size and forecast
      • 4.3.4.2.Disinfectors equipment
      • 4.3.4.2.1.Market size and forecast
      • 4.3.4.3.Others
      • 4.3.4.3.1.Market size and forecast
  • 4.4.Protective Barriers
    • 4.4.1.Key market trends, growth factors, and opportunities
    • 4.4.2.Market size and forecast, by region
    • 4.4.3.Market analysis, by country
    • 4.4.4.Market size and forecast, by type
      • 4.4.4.1.Medical Nonwoven
      • 4.4.4.1.1.Market size and forecast
      • 4.4.4.1.2.Market size and forecast, by type
      • 4.4.4.1.2.1.Surgical gowns
      • 4.4.4.1.2.1.1.Market size and forecast
      • 4.4.4.1.2.2.Face masks
      • 4.4.4.1.2.2.1.Market size and forecast
      • 4.4.4.1.2.3.Coveralls
      • 4.4.4.1.2.3.1.Market size and forecast
      • 4.4.4.1.2.4.Others
      • 4.4.4.1.2.4.1.Market size and forecast
      • 4.4.4.2.Gloves
      • 4.4.4.2.1.Market size and forecast
  • 4.5.Endoscope reprocessing products
    • 4.5.1.Key market trends, growth factors, and opportunities
    • 4.5.2.Market size and forecast, by region
    • 4.5.3.Market analysis, by country

CHAPTER 5:INFECTION CONTROL MARKET, BY END USER

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Hospitals & clinics
    • 5.2.1.Market size and forecast, by region
    • 5.2.2.Market analysis, by country
  • 5.3.Pharmaceutical & medical device companies
    • 5.3.1.Market size and forecast, by region
    • 5.3.2.Market analysis, by country
  • 5.4.Others
    • 5.4.1.Market size and forecast, by region
    • 5.4.2.Market analysis, by country

CHAPTER 6:INFECTION CONTROL MARKET, BY REGION

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.North America
    • 6.2.1.Key market trends, growth factors, and opportunities
    • 6.2.2.Market size and forecast, by country
      • 6.2.2.1.U.S.
      • 6.2.2.1.1.U.S. infection control market, by product & service
      • 6.2.2.1.2.U.S. infection control market, by end user
      • 6.2.2.2.Canada
      • 6.2.2.2.1.Canada infection control market, by product & service
      • 6.2.2.2.2.Canada infection control market, by end user
      • 6.2.2.3.Mexico
      • 6.2.2.3.1.Mexico infection control market, by product & service
      • 6.2.2.3.2.Mexico infection control market, by end user
    • 6.2.3.North America market size and forecast, by product & service
    • 6.2.4.North America market size and forecast, by end user
  • 6.3.Europe
    • 6.3.1.Key market trends, growth factors, and opportunities
    • 6.3.2.Market size and forecast, by country
      • 6.3.2.1.Germany
      • 6.3.2.1.1.Germany infection control market, by product & service
      • 6.3.2.1.2.Germany infection control market, by end user
      • 6.3.2.2.France
      • 6.3.2.2.1.France infection control market, by product & service
      • 6.3.2.2.2.France infection control market, by end user
      • 6.3.2.3.UK
      • 6.3.2.3.1.UK infection control market, by product & service
      • 6.3.2.3.2.UK infection control market, by end user
      • 6.3.2.4.Italy
      • 6.3.2.4.1.Italy infection control market, by product & service
      • 6.3.2.4.2.Italy infection control market, by end user
      • 6.3.2.5.Spain
      • 6.3.2.5.1.Spain infection control market, by product & service
      • 6.3.2.5.2.Spain infection control market, by end user
      • 6.3.2.6.Rest of Europe
      • 6.3.2.6.1.Rest of Europe infection control market, by product & service
      • 6.3.2.6.2.Rest of Europe infection control market, by end user
    • 6.3.3.Europe market size and forecast, by product & service
    • 6.3.4.Europe market size and forecast, by end user
  • 6.4.Asia-Pacific
    • 6.4.1.Key market trends, growth factors, and opportunities
    • 6.4.2.Market size and forecast, by country
      • 6.4.2.1.Japan
      • 6.4.2.1.1.Japan infection control market, by product & service
      • 6.4.2.1.2.Japan infection control market, by end user
      • 6.4.2.2.China
      • 6.4.2.2.1.China infection control market, by product & service
      • 6.4.2.2.2.China infection control market, by end user
      • 6.4.2.3.Australia
      • 6.4.2.3.1.Australia infection control market, by product & service
      • 6.4.2.3.2.Australia infection control market, by end user
      • 6.4.2.4.India
      • 6.4.2.4.1.India infection control market, by product & service
      • 6.4.2.4.2.India infection control market, by end user
      • 6.4.2.5.South Korea
      • 6.4.2.5.1.South Korea infection control market, by product & service
      • 6.4.2.5.2.South Korea infection control market, by end user
      • 6.4.2.6.Rest of Asia-Pacific
      • 6.4.2.6.1.Rest of Asia-Pacific infection control market, by product & service
      • 6.4.2.6.2.Rest of Asia-Pacific infection control market, by end user
    • 6.4.3.Asia-Pacific market size and forecast, by product & service
    • 6.4.4.Asia-Pacific market size and forecast, by end user
  • 6.5.LAMEA
    • 6.5.1.Key market trends, growth factors, and opportunities
    • 6.5.2.Market size and forecast, by country
      • 6.5.2.1.Brazil
      • 6.5.2.1.1.Brazil infection control market, by product & service
      • 6.5.2.1.2.Brazil infection control market, by end user
      • 6.5.2.2.Saudi Arabia
      • 6.5.2.2.1.Saudi Arabia infection control market, by product & service
      • 6.5.2.2.2.Saudi Arabia infection control market, by end user
      • 6.5.2.3.South Africa
      • 6.5.2.3.1.South Africa infection control market, by product & service
      • 6.5.2.3.2.South Africa infection control market, by end user
      • 6.5.2.4.Rest of LAMEA
      • 6.5.2.4.1.Rest of LAMEA infection control market, by product & service
      • 6.5.2.4.2.Rest of LAMEA infection control market, by end user
    • 6.5.3.LAMEA market size and forecast, by product & service
    • 6.5.4.LAMEA market size and forecast, by end user

CHAPTER 7:COMPANY PROFILES

  • 7.1.3M COMPANY
    • 7.1.1.Company overview
    • 7.1.2.Company snapshot
    • 7.1.3.Operating business segments
    • 7.1.4.Product portfolio
    • 7.1.5.Business performance
    • 7.1.6.Key strategic moves and developments
  • 7.2.BELIMED AG.
    • 7.2.1.Company overview
    • 7.2.2.Company snapshot
    • 7.2.3.Operating business segments
    • 7.2.4.Product portfolio
    • 7.2.5.Business performance
  • 7.3.ECOLAB INC.
    • 7.3.1.Company overview
    • 7.3.2.Company snapshot
    • 7.3.3.Operating business segments
    • 7.3.4.Product portfolio
    • 7.3.5.Business performance
    • 7.3.6.Key strategic moves and developments
  • 7.4.FORTIVE CORPORATION (ADVANCED STERILIZATION PRODUCTS).
    • 7.4.1.Company overview
    • 7.4.2.Company snapshot
    • 7.4.3.Operating business segments
    • 7.4.4.Product portfolio
    • 7.4.5.Business performance
    • 7.4.6.Key strategic moves and developments
  • 7.5.GENITGE AB.
    • 7.5.1.Company overview
    • 7.5.2.Company snapshot
    • 7.5.3.Operating business segments
    • 7.5.4.Product portfolio
    • 7.5.5.Business performance
    • 7.5.6.Key strategic moves and developments
  • 7.6.MATACHANA GROUP.
    • 7.6.1.Company overview
    • 7.6.2.Company snapshot
    • 7.6.3.Operating business segments
    • 7.6.4.Product portfolio
    • 7.6.5.Key strategic moves and developments
  • 7.7.MIELE GROUP. (STEELCO)
    • 7.7.1.Company overview
    • 7.7.2.Company snapshot
    • 7.7.3.Operating business segments
    • 7.7.4.Product portfolio
  • 7.8.MMM GROUP
    • 7.8.1.Company overview
    • 7.8.2.Company snapshot
    • 7.8.3.Operating business segments
    • 7.8.4.Product portfolio
  • 7.9.SOTERA HEALTH INC.
    • 7.9.1.Company overview
    • 7.9.2.Company snapshot
    • 7.9.3.Operating business segments
    • 7.9.4.Product portfolio
    • 7.9.5.Business performance
    • 7.9.6.Key strategic moves and developments
  • 7.10.STERIS PLC (CANTEL MEDICAL CORPORATION).
    • 7.10.1.Company overview
    • 7.10.2.Company snapshot
    • 7.10.3.Operating business segments
    • 7.10.4.Product portfolio
    • 7.10.5.Business performance
    • 7.10.6.Key strategic moves and developments

LIST OF TABLES

  • TABLE 01.INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
  • TABLE 02.INFECTION CONTROL MARKET FOR STERILIZATION, BY REGION, 2020-2028 ($MILLION)
  • TABLE 03.STERILIZATION INFECTION CONTROL MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 04.STERILIZATION PRODUCT MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 05.CONTRACT STERILIZATION SERVICES MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 06.STERILIZATION CONSUMABLES AND ACCESSORIES MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 07.INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 08.CLEANING & DISINFECTION PRODUCTS INFECTION CONTROL MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 09.DISINFECTANTS MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 10.INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 11.INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 12.MEDICAL NONWOVEN MARKET, BY TYPE, 2020-2028 ($MILLION)
  • TABLE 13.INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 14.INFECTION CONTROL MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 15.INFECTION CONTROL MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 16.INFECTION CONTROL MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE COMPANIES, BY REGION, 2020-2028 ($MILLION)
  • TABLE 17.INFECTION CONTROL MARKET FOR OTHERS, BY REGION, 2020-2028 ($MILLION)
  • TABLE 18.INFECTION CONTROL MARKET, BY REGION, 2020-2028 ($MILLION)
  • TABLE 19.NORTH AMERICA INFECTION CONTROL MARKET, BY COUNTRY, 2020-2028 ($MILLION)
  • TABLE 20.U.S. INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
  • TABLE 21.U.S. INFECTION CONTROL MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 22.CANADA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
  • TABLE 23.CANADA INFECTION CONTROL MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 24.MEXICO INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
  • TABLE 25.MEXICO INFECTION CONTROL MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 26.NORTH AMERICA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
  • TABLE 27.NORTH AMERICA INFECTION CONTROL MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 28.EUROPE INFECTION CONTROL MARKET, BY COUNTRY, 2020-2028 ($MILLION)
  • TABLE 29.GERMANY INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
  • TABLE 30.GERMANY INFECTION CONTROL MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 31.FRANCE INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
  • TABLE 32.FRANCE INFECTION CONTROL MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 33.UK INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
  • TABLE 34.UK INFECTION CONTROL MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 35.ITALY INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
  • TABLE 36.ITALY INFECTION CONTROL MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 37.SPAIN INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
  • TABLE 38.SPAIN INFECTION CONTROL MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 39.REST OF EUROPE INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
  • TABLE 40.REST OF EUROPE INFECTION CONTROL MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 41.EUROPE INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
  • TABLE 42.EUROPE INFECTION CONTROL MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 43.ASIA-PACIFIC INFECTION CONTROL MARKET, BY COUNTRY, 2020-2028 ($MILLION)
  • TABLE 44.JAPAN INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
  • TABLE 45.JAPAN INFECTION CONTROL MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 46.CHINA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
  • TABLE 47.CHINA INFECTION CONTROL MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 48.AUSTRALIA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
  • TABLE 49.AUSTRALIA INFECTION CONTROL MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 50.INDIA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
  • TABLE 51.INDIA INFECTION CONTROL MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 52.SOUTH KOREA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
  • TABLE 53.SOUTH KOREA INFECTION CONTROL MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 54.REST OF ASIA-PACIFIC INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
  • TABLE 55.REST OF ASIA-PACIFIC INFECTION CONTROL MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 56.ASIA-PACIFIC INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
  • TABLE 57.ASIA-PACIFIC INFECTION CONTROL MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 58.LAMEA INFECTION CONTROL MARKET, BY COUNTRY, 2020-2028 ($MILLION)
  • TABLE 59.BRAZIL INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
  • TABLE 60.BRAZIL INFECTION CONTROL MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 61.SAUDI ARABIA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
  • TABLE 62.SAUDI ARABIA INFECTION CONTROL MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 63.SOUTH AFRICA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
  • TABLE 64.SOUTH AFRICA INFECTION CONTROL MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 65.REST OF LAMEA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
  • TABLE 66.REST OF LAMEA INFECTION CONTROL MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 67.LAMEA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
  • TABLE 68.LAMEA INFECTION CONTROL MARKET, BY END USER, 2020-2028 ($MILLION)
  • TABLE 69.3M: COMPANY SNAPSHOT
  • TABLE 70.3M: OPERATING SEGMENTS
  • TABLE 71.3M: PRODUCT PORTFOLIO
  • TABLE 72.BELIMED: COMPANY SNAPSHOT
  • TABLE 73.BELIMED: OPERATING SEGMENTS
  • TABLE 74.BELIMED: PRODUCT PORTFOLIO
  • TABLE 75.ECOLAB: COMPANY SNAPSHOT
  • TABLE 76.ECOLAB: OPERATING SEGMENTS
  • TABLE 77.ECOLAB: PRODUCT PORTFOLIO
  • TABLE 78.FORTIVE: COMPANY SNAPSHOT
  • TABLE 79.FORTIVE: OPERATING SEGMENTS
  • TABLE 80.FORTIVE: PRODUCT PORTFOLIO
  • TABLE 81.GENITGE: COMPANY SNAPSHOT
  • TABLE 82.GETINGE: OPERATING SEGMENTS
  • TABLE 83.GETINGE: PRODUCT PORTFOLIO
  • TABLE 84.MATACHNA: COMPANY SNAPSHOT
  • TABLE 85.MATACHANA: OPERATING SEGMENTS
  • TABLE 86.MATACHANA: PRODUCT PORTFOLIO
  • TABLE 87.MIELE: COMPANY SNAPSHOT
  • TABLE 88.MIELE: OPERATING SEGMENTS
  • TABLE 89.MIELE: PRODUCT PORTFOLIO
  • TABLE 90.MMM COMPANY SNAPSHOT
  • TABLE 91.MMM: OPERATING SEGMENTS
  • TABLE 92.MMM: PRODUCT PORTFOLIO
  • TABLE 93.SOTERA HEALTH: COMPANY SNAPSHOT
  • TABLE 94.SOTERA HEALTH: OPERATING SEGMENTS
  • TABLE 95.SOTERA HEALTH: PRODUCT PORTFOLIO
  • TABLE 96.STERIS: COMPANY SNAPSHOT
  • TABLE 97.STERIS: OPERATING SEGMENTS
  • TABLE 98.STERIS: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.INFECTION CONTROL MARKET SEGMENTATION
  • FIGURE 02.TOP INVESTMENT POCKETS
  • FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018-2020
  • FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2020
  • FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018-2020
  • FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 08.HIGH THREAT OF SUBSTITUTES
  • FIGURE 09.HIGH THREAT OF NEW ENTRANTS
  • FIGURE 10.MODERATE INTENSITY OF RIVALRY
  • FIGURE 11.TOP PLAYER POSITIONING, 2020
  • FIGURE 12.IMPACT ANALYSIS
  • FIGURE 13.COMPARATIVE ANALYSIS OF INFECTION CONTROL MARKET FOR STERILIZATION, BY COUNTRY, 2020 & 2028 ($MILLION)
  • FIGURE 14.STERILIZATION PRODUCT MARKET, 2020-2028 ($MILLION)
  • FIGURE 15.HEAT STERILIZATION EQUIPMENT MARKET, 2020-2028 ($MILLION)
  • FIGURE 16.LOW TEMPERATURE STERILIZATION EQUIPMENT MARKET, 2020-2028 ($MILLION)
  • FIGURE 17.RADIATION STERILIZATION EQUIPMENT MARKET, 2020-2028 ($MILLION)
  • FIGURE 18.OTHER STERILIZATION EQUIPMENT MARKET, 2020-2028 ($MILLION)
  • FIGURE 19.CONTRACT STERILIZATION SERVICES MARKET, 2020-2028 ($MILLION)
  • FIGURE 20.ETHYLENE OXIDE STERILIZATION MARKET, 2020-2028 ($MILLION)
  • FIGURE 21.E-BEAM STERILIZATION MARKET, 2020-2028 ($MILLION)
  • FIGURE 22.GAMMA STERILIZATION MARKET, 2020-2028 ($MILLION)
  • FIGURE 23.OTHERS STERILIZATION MARKET, 2020-2028 ($MILLION)
  • FIGURE 24.STERILIZATION CONSUMABLES AND ACCESSORIES MARKET, 2020-2028 ($MILLION)
  • FIGURE 25.STERILIZATION INDICATORS MARKET, 2020-2028 ($MILLION)
  • FIGURE 26.PACKAGING ACCESSORIES MARKET, 2020-2028 ($MILLION)
  • FIGURE 27.COMPARATIVE ANALYSIS OF INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY COUNTRY, 2020 & 2028 ($MILLION)
  • FIGURE 28.DISINFECTANTS MARKET, 2020-2028 ($MILLION)
  • FIGURE 29.WIPES MARKET, 2020-2028 ($MILLION)
  • FIGURE 30.LIQUIDS MARKET, 2020-2028 ($MILLION)
  • FIGURE 31.SPRAYS MARKET, 2020-2028 ($MILLION)
  • FIGURE 32.DISINFECTORS EQUIPMENT MARKET, 2020-2028 ($MILLION)
  • FIGURE 33.OTHERS CLEANING & DISINFECTION PRODUCTS MARKET, 2020-2028 ($MILLION)
  • FIGURE 34.COMPARATIVE ANALYSIS OF INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY COUNTRY, 2020 & 2028 ($MILLION)
  • FIGURE 35.MEDICAL NONWOVEN MARKET, 2020-2028 ($MILLION)
  • FIGURE 36.SURGICAL GOWNS MARKET, 2020-2028 ($MILLION)
  • FIGURE 37.FACE MASKS MARKET, 2020-2028 ($MILLION)
  • FIGURE 38.COVERALLS MARKET, 2020-2028 ($MILLION)
  • FIGURE 39.OTHERS MEDICAL NONWOVEN MARKET, 2020-2028 ($MILLION)
  • FIGURE 40.GLOVES MARKET, 2020-2028 ($MILLION)
  • FIGURE 41.COMPARATIVE ANALYSIS OF INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY COUNTRY, 2020 & 2028 ($MILLION)
  • FIGURE 42.COMPARATIVE ANALYSIS OF INFECTION CONTROL MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020 & 2028 ($MILLION)
  • FIGURE 43.COMPARATIVE ANALYSIS OF INFECTION CONTROL MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE COMPANIES, BY COUNTRY, 2020 & 2028 ($MILLION)
  • FIGURE 44.COMPARATIVE ANALYSIS OF INFECTION CONTROL MARKET FOR OTHERS, BY COUNTRY, 2020 & 2028 ($MILLION)
  • FIGURE 45.3M:NET SALES,2018-2020 ($MILLION)
  • FIGURE 46.3M: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 47.3M: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 48.BELIMED:NET SALES, 2018-2020 ($MILLION)
  • FIGURE 49.BELIMED: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 50.BELIMED: REVENUE SHARE BY REGION 2020 (%)
  • FIGURE 51.ECOLAB: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 52.ECOLAB: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 53.ECOLAB: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 54.FORTIVE: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 55.FORTIVE: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 56.FORTIVE: REVENUE SHARE BY REGION 2020 (%)
  • FIGURE 57.GETINGE: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 58.GETINGE: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 59.GENTIGE: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 60.SOTERA HEALTH: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 61.SOTERA HEALTH: REVENUE SHARE BY SEGMENTS, 2020(%)
  • FIGURE 62.SOTERA HEALTH: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 63.STERIS: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 64.STERIS: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 65.STERIS: REVENUE SHARE BY REGION, 2020 (%)